Prospective study on the relationship between clinical efficacy of secondary hormone therapy with flutamide and neuroendocrine differentiation in patients with relapsed prostate cancer after first line hormone therapy-Reference-Cited by-同舟云学术

Prospective study on the relationship between clinical efficacy of secondary hormone therapy with flutamide and neuroendocrine differentiation in patients with relapsed prostate cancer after first line hormone therapy

Published:2014-04-15 Issue:5 Volume:48 Page:436-444
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

Hirano Daisaku,Hasegawa Ryo,Satoh Katsuhiko,Mochida Junichi,Yamanaka Yataroh,Hirakata Hitoshi,Yamaguchi Kenya,Sugimoto Shuji,Kawata Nozomu,Takahashi Satoru

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

http://www.tandfonline.com/doi/pdf/10.3109/21681805.2014.905633

Reference33 articles.

1. Epidemiology of prostate cancer

2. Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression

3. Alternative Antiandrogens to Treat Prostate Cancer Relapse After Initial Hormone Therapy

4. ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Critical Approach to Clinical Biochemistry of Chromogranin A;Advances in Cancer Biomarkers;2015

2. Neuroendocrine differentiation in prostate cancer: Novel morphological insights and future therapeutic perspectives;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2014-12

3. Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts;Proceedings of the National Academy of Sciences;2014-09-29